Dr. Lawrence Pfeffer's lab focuses on understanding and treating glioblastoma, a deadly type of brain cancer. The lab investigates how certain molecular pathways impact the resistance of brain tumor cells to treatment and aims to develop new strategies that enhance the effectiveness of existing therapies. Using various experimental techniques, the lab seeks to make significant advances in the fight against this challenging disease.

Dr. Tiffany M. Schmidt's lab at Northwestern University focuses on understanding the genetic factors that influence the diversity of intrinsically photosensitive retinal ganglion cells (ipRGCs) in the retina. These specialized cells are crucial for various physiological responses to light. By studying these cells, the lab aims to uncover how different subtypes of ipRGCs are formed and how they function, which could enhance our understanding of the retina and the nervous system as a whole.

Dr. Wendy L. Picking's research lab focuses on developing vaccines to prevent infections caused by the antibiotic-resistant bacterium Pseudomonas aeruginosa. The lab explores innovative vaccine formulations that can stimulate an immune response to provide protection against this opportunistic pathogen, particularly in vulnerable populations like the elderly and patients with chronic conditions. By utilizing animal models, the lab assesses the effectiveness of these vaccines to ultimately enhance public health outcomes.

Dr. Charleen T Chu's lab focuses on understanding how a protein called PINK1 affects brain cells, particularly in conditions like Parkinson's disease and Lewy body dementia. By studying how PINK1 regulates the structure and function of dendrites, which are vital for neuronal communication and memory, the lab aims to uncover new approaches for preventing cognitive decline associated with neurodegenerative diseases.

The lab led by Dr. Daniele Piomelli at UC Irvine focuses on pain management, particularly by targeting a specific enzyme called NAAA to develop new pain medications that do not carry the risk of addiction. The research primarily explores how inhibiting this enzyme could lead to effective treatments for people suffering from acute and chronic pain. By studying animal models, the lab aims to uncover the cellular mechanisms involved in pain processing and to improve drug candidates for safer pain relief.

Dr. Mana M Parast's lab focuses on understanding the complex biology of the human placenta, particularly how its structure and function relate to pregnancy outcomes such as preeclampsia and fetal growth restriction. They utilize advanced techniques in single-cell analysis and tissue modeling to explore the properties of placental cells and their interactions, aiming to enhance our understanding of placental dysfunction and develop potential regenerative strategies. This research is crucial as it reveals insights into conditions like Trisomy 21, which significantly affects placental health and fetal development.

Dr. Mariko Horii's lab at UC San Diego focuses on understanding preeclampsia, a serious condition during pregnancy that can have severe consequences for both mothers and their babies. By modeling placental defects with stem cells, the lab aims to identify the underlying mechanisms of this disease and improve treatment options. Their research seeks to establish better diagnostic tools and therapeutic targets to enhance prenatal care and health outcomes.

Dr. Rashmi Sood's lab studies placental abruption, a serious pregnancy complication that occurs when the placenta separates from the uterus before delivery. The lab focuses on understanding the interplay between blood clotting and inflammation in this condition, using mouse models to investigate how specific immune cells and molecular processes contribute to placental damage. The ultimate goal is to identify potential therapeutic targets that could help prevent this dangerous complication in pregnancy.

In Jeffrey D. Axelrod's lab at Stanford University, researchers focus on understanding planar cell polarity (PCP) signaling, a critical process that ensures cells are correctly oriented and positioned within tissues. This signaling pathway is important for proper heart development and can lead to congenital heart defects when disrupted. The lab employs the fruit fly Drosophila as a model organism, using advanced genetic, imaging, and biochemical techniques to uncover the mechanisms behind PCP signaling. Their work not only advances basic biology but also aims to inform potential treatments for related diseases.

Dr. Ben N. Mansfeld's lab at Washington University explores how the timing of immune responses in plants, particularly through their internal biological clocks known as circadian rhythms, affects their defenses against pathogens. By studying a diverse group of plants called Solanum, the lab investigates how different environmental factors impact these rhythms and ultimately influence plant immunity. The research aims not only to advance our understanding of plant biology but also to draw parallels that could inform human health and disease treatments.

David M Allman's lab at the University of Pennsylvania focuses on understanding the survival mechanisms of plasma cells, which are crucial for producing antibodies in the immune system. They study how these cells adapt to their environments and resist therapies, particularly in diseases like multiple myeloma and during organ transplantation. The lab utilizes advanced techniques to explore the molecular pathways involved in plasma cell longevity and how they can be targeted for therapeutic interventions.

Dr. Maksim V Plikus' lab focuses on understanding how hair follicles control their growth and size. Using a combination of advanced techniques, including mouse models and computational analysis, the lab studies the interactions between different cell types within hair follicles. Their research aims to reveal the complex signaling mechanisms that allow tissues to maintain their intended size, which has important implications for both basic biology and potential medical applications.

Oleh Pochynyuk's lab at the University of Texas Health Science Center focuses on understanding how the kidneys regulate sodium levels and blood pressure, especially in the context of hypertension. They study a specific signaling pathway involving proteins called Epac1 and Epac2, which play important roles in sodium transport within the kidneys. By exploring how to effectively target these proteins with new drugs, the lab aims to develop better treatments for hypertension, a major health issue.

Dr. Leonidas Tsiokas's lab focuses on understanding how mutations in specific genes affect kidney function, specifically in conditions like Autosomal Dominant Polycystic Kidney Disease (ADPKD). His team seeks to uncover the role of the Polycystin complex—a group of proteins involved in kidney cyst formation—by exploring its function as a type of receptor that interacts with signaling molecules. Their research could lead to new treatments for kidney diseases.

Dr. Mauricio Henriques Pontes leads a research lab focused on understanding the unique interactions between a bacterium called Sodalis glossinidius and tsetse flies, which are known vectors for serious diseases like sleeping sickness. The lab aims to uncover how this bacterium survives and replicates within the fly, potentially paving the way for innovative strategies to control trypanosomiasis. By employing advanced genetic techniques, the lab explores how modifying this bacterium could help in producing flies that resist trypanosome infections.

Dr. Weston W. Porter's lab at Texas A&M is focused on understanding how biological clocks affect various cellular processes, particularly in the mammary gland. The research explores how disruptions to circadian rhythms can lead to significant health issues, including metabolic disorders and cancer. By investigating the roles of specific factors like PER2, the lab aims to uncover the molecular mechanisms that underlie cell differentiation and homeostasis.

The lab led by Colin G. Nichols at Washington University investigates how potassium channels influence insulin secretion and cardiovascular health. By studying both the molecular mechanisms of these channels and their role in diseases like diabetes and cardiovascular disorders, the lab aims to develop new therapies that can mitigate these conditions. Their work involves a mix of animal models and cell biology to better understand these important biological processes.

Dr. Daniel Swale's lab at the University of Florida studies how potassium channels influence the immune response to viruses. By examining these channels in various organisms, including insects and mammals, the research aims to uncover how potassium levels affect antiviral responses and could inform new therapeutic strategies. The lab will explore the connections between ion channels, immune function, and viral replication, contributing to a better understanding of viral infections and potential interventions.

Dr. Daniel J. Powell's lab focuses on developing advanced CAR T cell therapies for treating solid tumors, particularly ovarian cancer. Their innovative approach combines gene-engineered T cells with imaging techniques to monitor treatment effectiveness and adjust therapies as needed. This multidisciplinary effort aims to leverage the body's immune system to effectively target cancer cells while minimizing toxic side effects.

Dr. Nathaniel James Rhodes leads a research lab focused on the development of Precision Dosing strategies for antibiotic treatment in patients suffering from severe pneumonia caused by antibiotic-resistant bacteria. The lab uses innovative pharmacokinetic (PK) models to optimize beta-lactam antibiotic dosing, aiming to improve patient outcomes and reduce treatment failures. Through this work, the lab addresses critical public health challenges associated with antibiotic resistance.